Hoyoung M. Maeng, M.D.
Dr. Maeng’s research interests focus on therapeutic vaccines in cancer as well as novel strategies to treat precancerous lesions in patients with chronic viral infection. She believes that the essence of the Center for Cancer Research, NCI is the "bench-to-bedside" exemplfied by the vaccine that was created here at NCI to treat patients in the NIH Clinical Center. She leads the clinical trials team in the Vaccine Branch as a clinical PI.
A Randomized, Placebo-Controlled Phase II Study of Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men with Stage D0 Prostate CancerOpen - RecruitingNCI Protocol ID NCI-15-C-0075Investigator Hoyoung M. Maeng, M.D.
A Phase I Study of an Adenoviral Transduced Autologous Dendritic Cell Vaccine Expressing Human HER2/neu ECTM in Adults with Tumors with 1-3+ HER2/neu ExpressionOpen - RecruitingNCI Protocol ID NCI-13-C-0016Investigator Hoyoung M. Maeng, M.D.
Dr. Maeng's clinical research involves therapeutic vaccines to harness a patient's own immune system to fight against cancer or chronic infections. The Vaccine Branch clinical team is exploring various strategies to broaden cancer treatment options with lower toxicity customized to individuals.
Selected Key Publications
- Current Opnion in Immunology. 51: 111-122, 2018. [ Journal Article ]
- J. Natl. Cancer Inst. 101(6): 399-411, 2009. [ Journal Article ]
- Blood. 109(5): 2174-82, 2007. [ Journal Article ]
Dr. Maeng graduated from Yonsei University College of Medicine, Seoul, South Korea with an M.D. in 1998. She started her first research project in Yonsei Cancer Center as a medical student where she first developed an interest in translational medicine. She completed her residency in internal medicine followed by a fellowship in hematology and oncology at Severance Hospital, Yonsei University. Further training at the Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center as a research fellow in 2005 provided her with a deeper insight into the understanding of viral oncoprotein and cancer. Based on the work done at that time, she was awarded the AACR-MedImmune Fellowship in 2007. After serving in the public health system for Korean National Insurance as a physician treating patients with hematologic malignancies, she returned to the U.S. and completed her internal medicine residency at MetroWest Medical Center, Framingham, MA. She then completed a leukemia fellowship at the University of Texas MD Anderson Cancer Center, followed by a fellowship in medical oncology at NCI.
|Lee England P.A.||Physician Assistant|
|Laura Wisch R.N.||Senior Research Nurse Specialist|
|Giselle Martinez||Data Manager (Contr.)|
|Brittni Moore B.S.||Postbaccalaureate Fellow (CRTA)|